Pivotal phase III trial of TOL 101 vs thymoglobulin for the prevention of acute renal transplant rejection.
Latest Information Update: 02 Nov 2012
At a glance
- Drugs TOL 101 (Primary) ; Antithymocyte globulin
- Indications Renal transplant rejection
- Focus Registrational; Therapeutic Use
- 02 Nov 2012 New trial record